Browsing by Yonsei Author : Ahn, Sang Hoon

eperson profile image
Name:
Ahn, Sang Hoon [안상훈]
orcid http://orcid.org/0000-0002-3629-4624
Department :
College of Medicine (의과대학) - Dept. of Internal Medicine (내과학교실)
Scopus ID :
Scopus (7401989551)

Keyword Cloud

Researcher Network

Showing results 1 to 50 of 511

This table browses all dspace content
Issue DateTitleJournal Title
2022Clinical Indication of Aspirin Associated With Reduced Risk of Liver Cancer in Chronic Hepatitis B: A Nationwide Cohort StudyAMERICAN JOURNAL OF GASTROENTEROLOGY
2022Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levels JOURNAL OF HEPATOLOGY
2022Comparison of FibroScan-Aspartate Aminotransferase (FAST) Score and Other Non-invasive Surrogates in Predicting High-Risk Non-alcoholic Steatohepatitis Criteria FRONTIERS IN MEDICINE
2022Predictive Performance of CAGE-B and SAGE-B Models in Asian Treatment-Naive Patients Who Started Entecavir for Chronic Hepatitis BCLINICAL GASTROENTEROLOGY AND HEPATOLOGY
2022Cost-effectiveness of antiviral therapy in untreated compensated cirrhosis patient with serum HBV-DNA level < 2000 IU/mLHEPATOLOGY INTERNATIONAL
2022Prediction of Sustained Response After Nucleo(s)tide Analogue Cessation Using HBsAg and HBcrAg Levels: A Multicenter Study (CREATE) CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
2022Tenofovir is Associated With Higher Risk of Kidney Function Decline Than Entecavir in Patients With Chronic Hepatitis BCLINICAL GASTROENTEROLOGY AND HEPATOLOGY
2022Long-term renal safety between patients with chronic hepatitis B receiving tenofovir vs. entecavir therapy: A multicenter studyJOURNAL OF VIRAL HEPATITIS
2022Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease GUT AND LIVER
2022Advanced liver fibrosis measured by transient elastography predicts chronic kidney disease development in individuals with non-alcoholic fatty liver diseaseDIABETOLOGIA
2022Predictors of Sarcopenia in an Obese Asian PopulationNUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
2022Contextual and individual factors associated with knowledge, awareness and attitude on liver diseases: A large-scale Asian studyJOURNAL OF VIRAL HEPATITIS
2022Besifovir therapy improves hepatic histology and reduces covalently closed circular DNA in chronic hepatitis B patientsJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
2022A micellized bone morphogenetic protein-7 prodrug ameliorates liver fibrosis by suppressing transforming growth factor- β signaling AMERICAN JOURNAL OF CANCER RESEARCH
2022External Validation of the FSAC Model Using On-Therapy Changes in Noninvasive Fibrosis Markers in Patients with Chronic Hepatitis B: A Multicenter Study CANCERS
2022Validation of PH and Varices Risk Scores for Prediction of High-Risk Esophageal Varix and Bleeding in Patients with B-Viral Cirrhosis DIAGNOSTICS
2022Episodic Detectable Viremia Does Not Affect Prognosis in Untreated Compensated Cirrhosis With Serum Hepatitis B Virus DNA <2,000 IU/mLAMERICAN JOURNAL OF GASTROENTEROLOGY
2022Increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis with concurrent fatty liverALIMENTARY PHARMACOLOGY & THERAPEUTICS
2022Validation of Pre-/Post-TACE-Predict Models among Patients with Hepatocellular Carcinoma Receiving Transarterial Chemoembolization CANCERS
2022Long-term effects of entecavir and tenofovir treatment on the fibrotic burden in patients with chronic hepatitis BJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
2022Transarterial Radioembolization for Unresectable Hepatocellular Carcinoma: Real-Life Efficacy and Safety Analysis of Korean Patients CANCERS
2021Efficacy of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide in treatment-naive hepatitis B patientsHEPATOLOGY INTERNATIONAL
2021Novel Liver Stiffness-Based Nomogram for Predicting Hepatocellular Carcinoma Risk in Patients with Chronic Hepatitis B Virus Infection Initiating Antiviral Therapy CANCERS
2021No influence of hepatic steatosis on the 3-year outcomes of patients with quiescent chronic hepatitis BJOURNAL OF VIRAL HEPATITIS
2021YAP/TAZ Suppress Drug Penetration Into Hepatocellular Carcinoma Through Stromal ActivationHEPATOLOGY
2021Dickkopf-1 promotes angiogenesis by upregulating VEGF receptor 2-mediated mTOR/p70S6K signaling in hepatocellular carcinoma AMERICAN JOURNAL OF CANCER RESEARCH
2021Risk stratification using sarcopenia status among subjects with metabolic dysfunction-associated fatty liver disease JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE
2021Development and Pilot Testing of a Smartphone-Based Self-Care Program for Patients with Chronic Hepatitis B INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
2021Risk assessment of hepatocellular carcinoma and liver-related events using ultrasonography and transient elastography in patients with chronic hepatitis BJOURNAL OF VIRAL HEPATITIS
2021Effect of tenofovir alafenamide vs. tenofovir disoproxil fumarate on hepatocellular carcinoma risk in chronic hepatitis BJOURNAL OF VIRAL HEPATITIS
2021Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis BHEPATOLOGY INTERNATIONAL
2021Development and initial validation of the nonalcoholic fatty liver disease self-management questionnaireRESEARCH IN NURSING & HEALTH
2021Treatment efficacy by hepatic arterial infusion chemotherapy vs. sorafenib after liver-directed concurrent chemoradiotherapy for advanced hepatocellular carcinomaJOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
2021Screening, confirmation, and treatment rates of hepatitis C virus infection in a tertiary academic medical center in South KoreaJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
2021Hepatic Decompensation in Cirrhotic Patients Receiving Antiviral Therapy for Chronic Hepatitis BCLINICAL GASTROENTEROLOGY AND HEPATOLOGY
2021Liver Stiffness-Based Risk Prediction Model for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease CANCERS
2021Controlled attenuation parameter value and the risk of hepatocellular carcinoma in chronic hepatitis B patients under antiviral therapyHEPATOLOGY INTERNATIONAL
2021Pharmacokinetics and safety of evogliptin in hepatically impaired patientsBRITISH JOURNAL OF CLINICAL PHARMACOLOGY
2021The efficacies of entecavir and tenofovir in terms of enhancing prognosis after curative treatment of hepatitis B virus-related hepatocellular carcinomaEUROPEAN JOURNAL OF INTERNAL MEDICINE
2021Pathological predictive factors for late recurrence of hepatocellular carcinoma in chronic liver diseaseLIVER INTERNATIONAL
2021Direct-Acting Antivirals Improve Treatment Outcomes in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: A Nationwide, Multi-center, Retrospective Cohort StudyDIGESTIVE DISEASES AND SCIENCES
2021Clinical stage drugs targeting inhibitor of apoptosis proteins purge episomal Hepatitis B viral genome in preclinical models CELL DEATH & DISEASE
2021Dynamics of liver stiffness-based risk prediction model during antiviral therapy in patients with chronic hepatitis BEUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
2021Association between the severity of liver fibrosis and cardiovascular outcomes in patients with type 2 diabetesJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
2021External validation of CAGE-B and SAGE-B scores for Asian chronic hepatitis B patients with well-controlled viremia by antiviralsJOURNAL OF VIRAL HEPATITIS
2021Hepatitis B Core-Related Antigen: From Virology to Clinical ApplicationSEMINARS IN LIVER DISEASE
2021Change in the Recurrence Pattern and Predictors over Time after Complete Cure of Hepatocellular Carcinoma GUT AND LIVER
2021Lenvatinib is independently associated with the reduced risk of progressive disease when compared with sorafenib in patients with advanced hepatocellular carcinomaJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
2021The Prognostic Role of On-Treatment Liver Stiffness for Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B JOURNAL OF HEPATOCELLULAR CARCINOMA
2021Continuing besifovir dipivoxil maleate versus switching from tenofovir disoproxil fumarate for treatment of chronic hepatitis B: Results of 192-week phase 3 trial CLINICAL AND MOLECULAR HEPATOLOGY

Browse

Links